FMC Corporation Common Stock (FMC)

FairStock Score: 32/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses where price is modest relative to durable earning power. FMC is a global crop protection company, but the filed numbers show a business under severe stress. Revenue fell from $4.5B in fiscal year 2023, the year ended 2023-12-31, to $4.2B in fiscal year 2024, the year ended 2024-12-31, and $3.5B in fiscal year 2025, the year ended 2025-12-31. Net income went from $1.3B in fiscal year 2023 to $341.1M in fiscal year 2024 to a $2.2B loss in fiscal year 2025, with diluted EPS of $10.53, $2.72, and -$17.88, respectively. The pain continues: in fiscal Q1 2026, the quarter ended 2026-03-31, net income was -$281.3M, and in fiscal Q2 2026, the quarter ended 2026-06-30, net income was -$186.6M. That is not a stable moat; it is a cyclical and leveraged chemical franchise with weak pricing and cost pressure. Financial health is poor: D/E 2.65, Altman Z 1.09, ROE -88.38%, ROCE 0.58%, and the FairStock Score is 32/100. Still, at the 2026-10-13 close of $8.31, FairStock calculations show P/B 0.64, P/E -0.39, and an 8.1% FCF yield on $84.8M trailing free cash flow. Piotroski 7/9 and a 3.17% dividend yield offer some counterweight, but the negative P/E and losses mean book value and cash flow must be trusted. This is a classic Lynch TURNAROUND: loss in latest year after earlier profits. The price looks statistically cheap, but cheap can be a trap if debt and declining revenue persist. I would demand evidence of stabilized sales, positive earnings, and debt reduction before calling it a sound value.

In plain English: FMC makes chemicals that protect crops from insects, weeds, and disease. The business looks weak right now: sales are falling and it lost a lot of money last year, with more losses in early 2026. The share price looks low compared with its accounting asset value, but high debt and continuing losses mean it is not a clearly cheap, safe business.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q4 2025 10-K (period ended 2025-12-31) · fiscal Q3 2025 10-K (period ended 2025-09-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer